Takeda To Market Three New Drugs, Including Actos Version
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical says it has launched three new drugs in Japan, one a new version of its best-selling Actos (pioglitazone) diabetes drug